References
- Al-ZhoughbiWHuangJParamasivanGSTumor macroenvironment and metabolismSemin Oncol201441281 29524787299
- FingerECGiacciaAJHypoxia, inflammation, and the tumor microenvironment in metastatic diseaseCancer Metastasis Rev201029285 29320393783
- FearonKCHansellDTPrestonTInfluence of whole body protein turnover rate on resting energy expenditure in patients with cancerCancer Res1988482590 25953356019
- InculetRISteinTPPeacockJLAltered leucine metabolism in noncachectic sarcoma patientsCancer Res1987474746 47493621173
- CascinoAMuscaritoliMCangianoCPlasma amino acid imbalance in patients with lung and breast cancerAnticancer Res199515507 5107763031
- MaedaJHigashiyamaMImaizumiAPossibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control studyBMC Cancer20101069021176209
- NomuraDKCravattBFLipid metabolism in cancerBiochim Biophys Acta201318311497 149823921253
- LouieSMRobertsLSMulvihillMMLuoKNomuraDKCancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipidsBiochim Biophys Acta201318311566 157223872477
- Kuliszkiewicz-JanusMMałeckiRMohamedASLipid changes occuring in the course of hematological cancersCell Mol Biol Lett200813465 47418463797
- JaggersJRSuiXHookerSPMetabolic syndrome and risk of cancer mortality in menEur J Cancer2009451831 183819250819
- LarssonSCWolkAObesity and colon and rectal cancer risk: a meta-analysis of prospective studiesAm J Clin Nutr200786556 56517823417
- AuneDGreenwoodDCChanDSBody mass index, abdominal fatness and pancreatic cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studiesAnn Oncol201223843 85221890910
- OlsenCMNagleCMWhitemanDCBody size and risk of epithelial ovarian and related cancers: a population-based case-control studyInt J Cancer2008123450 45618449887
- JensenASharifHOlsenJHKjaerSKRisk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish womenAm J Epidemiol200816849 5718448441
- LarssonSCWolkAOverweight, obesity and risk of liver cancer: a meta-analysis of cohort studiesBr J Cancer2007971005 100817700568
- BhaskaranKDouglasIForbesHBody-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adultsLancet20143849945755 76525129328
- LevineWDyerARShekelleRBSchoenbergerJAStamlerJPost-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in IndustryAm J Epidemiol1990154 62
- StattinPBjörOFerrariPProspective study of hyperglycemia and cancer riskDiabetes Care2007561 56717327321
- MorimotoYConroySMOllberdingNJErythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin’s lymphoma risk in a nested case-control study: the multiethnic cohortCancer Causes Control201231693 170322907421
- Kucharska-NewtonAMRosamondWDSchroederJCHDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) studyLung Cancer200861292 30018342390
- KotaniKSekineYIshikawaSHigh-density lipoprotein and prostate cancer: an overviewJ Epidemiol201323313 31923985823
- Kucharska-NewtonAMRosamondWDMinkPJHDL-cholesterol and incidence of breast cancer in the ARIC cohort studyAnn Epidemiol200818671 67718794007
- GaardMTretliSUrdalPRisk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian womenCancer Causes Control19945501 5097827236
- WuermliLJoergerMHenzSHypertriglyceridemia as a possible risk factor for prostate cancerProstate Cancer Prostatic Dis20058316 32016158078
- BraunSBitton-WormsKLeRoithDThe link between the metabolic syndrome and cancerInt J Biol Sci201171003 101521912508
- BuurmanHSaegerWSubclinical adenomas in postmortem pituitaries: classification and correlations to clinical dataEur J Endocrinol2006154753 75816645024
- GreenmanYSternNNon-functioning pituitary adenomasBest Pract Res Clin Endocrinol Metab200923625 63819945027
- GillamMPMolitchMELombardiGColaoAAdvances in the treatment of prolactinomasEndocr Rev200627485 53416705142
- ColaoASarnoADCappabiancaPGender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemiaEur J Endocrinol2003148325 33112611613
- Ben-JonathanNHugoERBrandebourgTDLaPenseeCRFocus on prolactin as a metabolic hormoneTrends Endocrinol Metab200617110 11616517173
- HorrobinDFProlactin as a regulator of fluid and electrolyte metabolism in mammalsFed Proc1980392567 25706247216
- RabinowitzDZierlerKLA metabolic regulating device based on the actions of human growth hormone and of insulin, singly and together, on the human forearmNature1963199913 91514079908
- FieffeSMorangeIPetrossiansPDiabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly RegistryEur J Endocrinol2011164877 88421464140
- DrevalAVTrigolosovaIVMisnikovaIVPrevalence of diabetes mellitus in patients with acromegalyEndocr Connect2014393 9824692509
- BondanelliMBonadonnaSAmbrosioMRCardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantismMetabolism2005541174 118016125529
- WatersMJBrooksAJChhabraYA new mechanism for growth hormone receptor activation of JAK2, and implications for related cytokine receptorsJak-Stat20143e2956925101218
- JonesJIClemmonsDRInsulin-like growth factors and their binding proteins: biological actionsEndocr Rev1995163 347758431
- ParkSBBlumenthalJALeeSYGeorgiadesAAssociation of cortisol and the metabolic syndrome in Korean men and womenJ Korean Med Sci201126914 91821738345
- WebbSMMoDLambertsSWMetabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing’s disease or non-functioning pituitary adenomaJ Clin Endocrinol Metab201095630 63820022992
- Newell-PriceJBertagnaXGrossmanABNiemanLKCushing’s syndromeLancet20063671605 161716698415
- AnagnostisPAthyrosVGTziomalosKKaragiannisAMikhailidisDPClinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesisJ Clin Endocrinol Metab2009942692 270119470627
- MichailidouZCollAPKenyonCJPeripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosteroneJ Endocrinol2007194161 17017592030
- KrikorianAKhanMIs metabolic syndrome a mild form of Cushing’s syndrome?Rev Endocr Metab Disord201011141 14520711679
- RuhlaSWeickertMOArafatAMA high normal TSH is associated with the metabolic syndromeClin Endocrinol (Oxf)201072696 70120447068
- BassettJHDHarveyCBWilliamsGRMechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actionsMol Cell Endocrinol20032131 1115062569
- PucciEChiovatoLPincheraAThyroid and lipid metabolismInt J Obes Relat Metab Disord200024Suppl 2S109 S11210997623
- BarashIACheungCCWeigleDSLeptin is a metabolic signal to the reproductive systemEndocrinology19961373144 31478770941
- ColaoAGrassoLFSPivonelloRLombardiGTherapy of aggressive pituitary tumorsExpert Opin Pharmacother2011121561 157021434849
- ShirvaniMMotiei-LangroudiRTranssphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patientsWorld Neurosurg201481125 13023313263
- ChenYWangCDSuZPNatural history of postoperative non-functioning pituitary adenomas: a systematic review and meta-analysisNeuroendocrinology201296333 34222687984
- WangFZhouTWeiSEndoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomasSurg Endosc20142961270 128025270611
- Dos Santos SilvaCMBarbosaFRLimaGABMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonistsObes (Silver Spring)201119800 805
- ChengSAl-AghaRAraujoPBMetabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegalyPLoS One20138e7354324039977
- MøllerNJørgensenJOLEffects of growth hormone on glucose, lipid, and protein metabolism in human subjectsEndocr Rev200930152 17719240267
- GrundySMDrug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacyNat Rev Drug Discov20065295 30916582875